Taiwania Capital Management Corporation

Opsera is a provider of cloud-based continuous orchestration software aimed at automating CI/CD toolchains for software and DevOps engineers. Its platform facilitates self-service toolchain automation and offers features such as drag-and-drop declarative pipelines and unified insights. By enabling teams to select their preferred tools without scripting, Opsera enhances software delivery speed and efficiency while minimizing complexity and risk. The platform supports the entire DevOps lifecycle, allowing development teams to increase velocity, operations teams to improve efficiency, and business leaders to gain comprehensive visibility. Opsera's mission is to accelerate DevOps adoption, transforming it into a practical science that fosters peak innovation velocity within organizations.

Health2Sync is a provider of a mobile application aimed at enhancing diabetes management. The company's platform allows users to track vital health metrics, including blood glucose levels, blood pressure, and weight, while also considering lifestyle factors such as diet, exercise, and medication. The application offers features like analysis, reminders, and educational content to empower individuals with diabetes to better manage their condition. By connecting users with their loved ones and healthcare professionals, Health2Sync facilitates more personalized and effective care.

Syncell is a proteomics technology company focused on enabling targeted protein drug discovery related to specific diseases. The company's innovative Microscoop™ technology allows for microscopy-guided nanoscale protein "scooping," facilitating unbiased subcellular spatial proteomic discovery. This advancement makes it possible to address complex biological problems and identify novel disease biomarkers and druggable targets. Syncell's system transforms a high-content microscope into a precision photolabeling machine, aiding researchers in high-content de novo spatial proteomics to efficiently harvest proteins from selected subcellular locations. Through its technology, Syncell aims to significantly enhance the understanding of diseases and the development of targeted therapies.

Path Robotics, Inc., based in Cleveland, Ohio, specializes in the manufacture of autonomous welding robots. Founded in 2018, the company focuses on designing robotic welding systems that utilize artificial intelligence and machine learning to enhance precision and adaptability in manufacturing processes. These advanced systems automate repetitive welding tasks, helping manufacturers boost productivity while reducing initial costs. By addressing workforce challenges in the manufacturing sector, Path Robotics offers effective automation solutions that streamline operations. Their robots are engineered to autonomously locate and weld seams, significantly reducing production time and improving quality by minimizing errors and inconsistencies. This technology enables industries to simplify their production processes and enhance overall efficiency.

All Eyes on Screens is a company focused on enhancing the effectiveness of TV advertising through data-driven solutions. By integrating proprietary technologies, the firm aims to provide advertisers with a platform that improves transparency and speed while simplifying the reporting process. Their platform collects, integrates, extracts, and visualizes data, allowing clients to access real-time insights and event-based notifications. This approach not only streamlines operations but also facilitates a more interconnected advertising experience between television and digital channels. Through these innovations, All Eyes on Screens seeks to empower advertisers to make informed decisions and optimize their advertising strategies.

DataPelago specializes in big data analytics solutions, offering a comprehensive platform that integrates both hardware and software products. This platform is designed to extract instantaneous insights from data, regardless of its scale, speed, or structure. By delivering high-performance and cost-effective solutions, DataPelago enables businesses to address complex challenges across various operational layers, enhancing their decision-making capabilities and overall efficiency.

TXOne Networks specializes in cybersecurity solutions aimed at safeguarding industrial control systems from cyber threats. The company develops industrial control systems for industrial IoT environments, such as smart manufacturing, smart cities, and smart energy, to enhance the protection of these critical infrastructures. TXOne Networks provides both network-based and endpoint-based products designed to secure operational technology (OT) networks and mission-critical devices through a real-time, defense-in-depth approach. Their solutions offer comprehensive visibility into ICS assets, protocols, control commands, risks, and threats, ensuring the reliability and safety of various industrial operations.

ARRIS specializes in additive molding technology for creating advanced performance composites tailored for mass-market applications such as aerospace, automotive, and consumer products. The company’s innovative manufacturing process focuses on the precise alignment of continuous carbon fibers, allowing for the integration of electronic components and multifunctional materials into a single, topologically optimized part. This technology enables clients to leverage high-performance composites, enhancing the capabilities and efficiency of their products while meeting the demands of modern manufacturing.

TransferGo is a global money transfer company that provides a cost-effective solution for migrant workers to send money to their families abroad. By employing a digital account-to-account business model, it allows users to transfer funds internationally without incurring unnecessary bank fees. The company operates as a licensed payment institution, ensuring secure transactions under the supervision of relevant financial authorities. TransferGo’s platform enables users to make transfers at significantly lower costs compared to traditional banks and cash bureaus, often with same-day delivery. The service charges a fixed fee for transfers and a currency conversion fee ranging from 0.6% to 1.5%, making it an attractive option for both individuals and businesses looking to pay suppliers internationally.

Daytrip Europe Ltd is a travel platform that connects tourists with local drivers for inter-city transportation. Founded in 2015 and based in London, the platform allows travelers to book private door-to-door transfers by entering their origin and destination. This service not only facilitates convenient travel between cities but also offers an opportunity to explore local sights and culture during the journey. Travelers can experience the region's countryside and engage with local drivers, enhancing their vacation with authentic insights into the area's history and customs. Daytrip aims to combine the comfort of traditional travel with the flexibility of independent exploration, making it a unique option for those seeking a more immersive travel experience.

SKY ENGINE AI is a synthetic data cloud generative AI platform for data scientists enabling ai computer vision at scale software allows creating a digital twin of your sensor, drone, or robot and putting them through testing and training in a virtual environment prior to real-world deployment. They are data generation makes data scientist life easier providing perfectly balanced datasets for any computer vision applications like object detection and recognition. They include 3d positioning, pose estimation, and other sophisticated cases including analysis of multi-sensor data radars, lidars, satellites, x-rays, and more.

VRgineers, Inc. is a prominent developer and manufacturer of high-resolution virtual reality solutions, specializing in the creation of advanced virtual reality headsets such as the XTAL. Founded in 2017 and headquartered in Dover, Delaware, with additional offices in Prague and Marina Del Rey, the company caters primarily to the automotive, aerospace, and defense sectors. The XTAL headset features cutting-edge technology, including a 5K OLED display, leap motion hand tracking, and a wide field of view, making it suitable for professional applications. VRgineers also offers a range of synthetic training systems for pilot training, developed in collaboration with industry professionals. These systems enhance situational awareness and training effectiveness, being utilized by clients such as the U.S. Air Force and NASA. The company has earned recognition for its innovative designs, including a Red Dot Product Design Award for the XTAL 8K headset. With a team of skilled professionals, VRgineers continues to push the boundaries of virtual reality technology to improve training and prototyping across various industries.

SURGLASSES is a medical innovative company that develops and markets a range of innovative products for use in medical education and surgical navigation solutions. SURGLASSES has developed its own patented technology in the high-performance surgical system and educational products as well. Our manufacturing company is located in Taichung, Taiwan with CE Mark, ISO-13485, and GMP(good manufacturing practice) certifications and we are manufacturing a series of FDA and CE approved medical equipment and devices, mainly aimed for surgical fields and educational purposes. Our product range gives a versatile, cost-effective alternative to major investments in surgical planning and guided tools. We are committed to achieve a significant share of the International market and developing creative solutions in the field of medical products. Bringing high-end and cutting-edge technology to medical, surgical, clinical, and health systems with innovations to make evolutionary improvements. We commit to meeting the needs of surgeons, physicians, patients, caregivers, educators by continuous R&D. Customers are assured of advanced medical experiences and outcomes with our integrated solutions, innovative products, and services. At Taiwan Main Orthopedic Biotechnology, we aim to be the pioneer that strives to make medical insights and contribute to the development in the field of medical electronics, minimally invasive surgery, intelligent medical informatics, real-time medical data digitization & information visualization, surgical navigation, medical augmented reality (AR) and mixed reality (MR). The Key products are Foresee-X and Caduceus, Foresee-X is the first CE-approved Smart surgical glasses with Augmented Reality technology for visualized medical imaging during surgery. The caduceus is a smart surgical glasses for very accurate spine surgical navigation with 3D Mixed Reality.

Opsera is a provider of cloud-based continuous orchestration software aimed at automating CI/CD toolchains for software and DevOps engineers. Its platform facilitates self-service toolchain automation and offers features such as drag-and-drop declarative pipelines and unified insights. By enabling teams to select their preferred tools without scripting, Opsera enhances software delivery speed and efficiency while minimizing complexity and risk. The platform supports the entire DevOps lifecycle, allowing development teams to increase velocity, operations teams to improve efficiency, and business leaders to gain comprehensive visibility. Opsera's mission is to accelerate DevOps adoption, transforming it into a practical science that fosters peak innovation velocity within organizations.

Flat Medical is a company that specializes in safety technology solutions designed for clinical processes, particularly during surgical procedures. Their innovative technology is focused on detecting and preventing surgical errors, thereby enhancing the safety of treatments provided by clinical professionals. By addressing critical aspects of patient care, Flat Medical aims to improve outcomes and ensure a higher standard of safety in surgical environments.

QT Medical develops innovative medical devices aimed at enhancing heart health management. The company provides a wireless electrocardiogram (ECG) that allows patients to conduct diagnostic tests conveniently from home or any location with internet access. This technology enables individuals to take an active role in managing their heart conditions, significantly reducing the need for trips to healthcare facilities. By offering hospital-grade ECG scans that display detailed data and minimize errors, QT Medical not only saves time and reduces stress for patients but also promotes better health outcomes. With heart disease being a leading cause of death globally, QT Medical's solutions empower patients to monitor their cardiac health safely and effectively.

Sensoneo is a provider of advanced smart waste management solutions that assist cities and businesses in managing waste more efficiently and sustainably. The company utilizes proprietary ultrasonic sensors to monitor waste levels in real-time, coupled with sophisticated software that facilitates data-driven decision-making and optimizes waste collection processes. This technology enables significant reductions in waste collection costs, with improvements in operational efficiency and a potential decrease in carbon emissions. Sensoneo's solutions have been implemented in various locations across Europe, North America, South America, the Middle East, Australia, and New Zealand, attracting a diverse range of clients seeking to enhance their waste management practices. By automating the waste lifecycle and promoting eco-friendly initiatives, Sensoneo aims to transform traditional waste management into a more transparent and responsible process.

Ethernovia is focused on creating a sophisticated Ethernet system capable of meeting the increasing bandwidth demands of future automotive technologies. The company's system integrates multiple levels of vehicle networks, allowing for significant advancements in vehicle design and construction. Key features of Ethernovia's solution include autonomous expansions, enhanced security intelligence, and optimized sensor bandwidths, all of which contribute to a unified network. This innovative approach enables clients to effectively transform and develop advanced vehicles, fundamentally changing how automotive systems are architected and built.

Developer of innovative protein degradation drugs designed to treat cancer, neurodegenerative and aging-related diseases. The company develops a drug pipeline, using an AI-enabled platform to discover drug candidates, which target and degrade disease-related proteins, enabling researchers, clinicians, and pharmaceutical companies to access a novel class of drugs that address life-threatening and life-impairing diseases plagued by drug resistance.

3drens is a provider of B2B software services specializing in fleet intelligence solutions for commercial fleet owners. The company operates a data-driven Internet of Vehicles platform that connects businesses to essential logistics services. This platform is designed to assist sectors such as vehicle rentals, logistics, transportation, and automakers in managing their fleets more efficiently. By offering low-cost and effective logistics management solutions, 3drens aims to enhance operational performance for its clients in the commercial fleet industry.

Genialis, Inc. is a computational precision medicine company that specializes in developing a web-based software platform for biological data management and analysis. Founded in 2015 and based in Houston, Texas, the platform provides a suite of visual analytics and bioinformatics tools, facilitating the storage, analysis, and sharing of biological data while ensuring transparency and security. The system automates primary analyses to enhance reproducibility and allows non-computational experts to access advanced downstream analyses. Genialis focuses on unraveling complex biology to identify actionable biomarkers, which aids pharmaceutical companies in developing effective drugs and diagnostics that improve treatment decisions. The company's efforts aim to enhance translational research and clinical development, ultimately benefiting patients and their families.

Light Field Lab, Inc. is a technology startup focused on developing holographic capture display systems. Founded in 2017 and based in San Jose, California, the company creates innovative solutions that generate three-dimensional holographic images that can be viewed from multiple angles without the need for head-mounted devices. Its technology aims to project 3D holograms into living spaces, allowing users to experience immersive visuals that respond dynamically to their viewpoint. Additionally, Light Field Lab offers integrated processing and imaging solutions designed to deliver these visuals over commercial network speeds. The company is also working on a universal application programming interface to facilitate the adaptation of existing content for its holographic displays. With a mission to enable a holographic future, Light Field Lab seeks to unlock new business opportunities across both consumer and enterprise markets.

Oxipit is a developer of artificial intelligence tools focused on enhancing medical imaging, particularly in the field of radiology. The company's primary offering is an AI-based chest X-ray radiology suite that automates the diagnosis and reporting process. This platform efficiently identifies healthy chest X-ray images and generates preliminary reports only when it is highly confident in the findings. By leveraging advancements in AI and machine learning, Oxipit aims to address the global shortage of radiologists and improve the overall quality of diagnostics. This innovation allows medical specialists to concentrate on cases that require further attention, ultimately contributing to better patient outcomes worldwide.

Photoneo s. r. o. is a Slovakian company that specializes in developing and selling advanced 3D sensing technology aimed at enhancing mobile robotics. Founded in 2013 and based in Bratislava, Photoneo offers a range of 3D scanners, including the Phoxi Scan XS, S, and M, which cater to various scanning area requirements. The company's Bin Picking solution enables robots to pick up randomly placed objects from containers. Photoneo leverages patented 3D technology to provide high-resolution and high-accuracy imaging, which facilitates machine learning applications in sectors such as automotive, logistics, e-commerce, food, and medical industries. By integrating smart vision systems and robotic intelligence, Photoneo supports businesses in improving their manufacturing, fulfillment, and assembly processes, ultimately enhancing overall operational efficiency.

Artilux specializes in the development of innovative technology solutions focused on optical connectivity and 3D time of flight (ToF) applications. The company offers a range of integrated circuit (IC) solutions that deliver high performance at competitive costs, catering to both short-range applications, such as consumer electronics with 10-40G capabilities, and long-range data center links with 100G performance. Artilux is also recognized for its discovery of GeSi, a groundbreaking 3D photosensitive material, which is poised to enhance the functionality of next-generation mobile devices. By incorporating advanced optical and radio frequency technologies, Artilux enables seamless data transfer for various applications, from everyday consumer use to complex cloud-based systems.

Litilit specializes in the development of ultra-short pulse lasers, offering advanced technology designed to meet the needs of the industrial laser market. Utilizing a patented laser pulse generator, Litilit achieves telecom-grade performance characterized by high reliability and scalability at competitive prices. The company's innovative femtosecond and self-starting laser technologies have proven to be effective across various industries, including medical equipment, bioimaging, consumer electronics, advanced manufacturing, 3D printing, and laser surgery. By leveraging its in-house expertise, Litilit provides tailored engineering solutions that deliver significant value to clients. This strategic approach positions the company as a leader in the next generation of laser technology, addressing the evolving demands of diverse sectors.

3nets, Inc. is a Santa Clara, California-based company specializing in MultiCloud Networking. It offers an applications-aware elastic network infrastructure platform known as Network Fabric, designed to meet the application delivery needs of enterprises. This software-defined, cloud-native WAN platform utilizes commercially available hardware owned by customers and integrates with public cloud infrastructure, facilitating the delivery of applications across multiple cloud environments. The platform enables businesses to automate and streamline their digital transformation initiatives by providing scalable end-to-end connectivity. It allows application-based workloads to be distributed across various locations, including cloud-centric data centers and branch offices, thereby accelerating innovation and reducing operational complexity for its clients.

DataPelago specializes in big data analytics solutions, offering a comprehensive platform that integrates both hardware and software products. This platform is designed to extract instantaneous insights from data, regardless of its scale, speed, or structure. By delivering high-performance and cost-effective solutions, DataPelago enables businesses to address complex challenges across various operational layers, enhancing their decision-making capabilities and overall efficiency.

Nanolive SA is a Swiss company that specializes in the design and development of advanced devices for scanning living cells. Established in 2013 and headquartered in Ecublens, the company has created the 3D Cell Explorer, a technology that allows researchers to visualize the interior of living cells in three dimensions without the need for labeling or invasive techniques. This device is capable of examining various cellular processes, including cell division, organelle function, morphology, differentiation, and interactions between cells. Nanolive's technology is particularly valuable in drug monitoring and in vitro fertilization, providing crucial insights for researchers in the fields of drug development and therapeutic discovery. The company's innovative approach aims to enhance the understanding of cellular dynamics, ultimately contributing to advancements in medical research and treatment.

Cognito Health focuses on enhancing the healthcare environment by delivering value to both patients and healthcare systems. The company has developed a global healthcare device that employs predictive algorithms to monitor patients continuously, providing a data-driven, contact-free solution. This technology alerts healthcare professionals to potential patient safety issues before they arise, such as the need for repositioning to prevent pressure-related injuries. By visually mapping pressure points, Cognito Health enables clinicians to respond proactively, improving patient outcomes and optimizing care delivery.

Health2Sync is a provider of a mobile application aimed at enhancing diabetes management. The company's platform allows users to track vital health metrics, including blood glucose levels, blood pressure, and weight, while also considering lifestyle factors such as diet, exercise, and medication. The application offers features like analysis, reminders, and educational content to empower individuals with diabetes to better manage their condition. By connecting users with their loved ones and healthcare professionals, Health2Sync facilitates more personalized and effective care.

Fractyl Health, based in Lexington, Massachusetts, specializes in developing innovative medical device solutions for metabolic diseases, particularly type 2 diabetes and obesity. The company’s primary offering, Revita DMR, is a minimally invasive therapy that utilizes hydrothermal ablation to rejuvenate the duodenal lining, which can become compromised due to high-fat and high-sugar diets. By focusing on durable disease-modifying therapies rather than just symptomatic management, Fractyl Health aims to address the underlying causes of metabolic diseases, improving patient outcomes and reducing healthcare burdens. Founded in 2010 and originally named MedCatalyst, Inc., the company envisions a future where less invasive, device-based therapies provide effective solutions for large populations affected by metabolic disorders.

PharmaEssentia Corporation is a biopharmaceutical company based in Taipei, Taiwan, focused on the research, development, production, and sale of therapeutic products aimed at treating various human diseases. The company specializes in areas such as hematology, oncology, and infectious diseases, with a product portfolio that includes ropeginterferon alfa-2b for polycythemia vera and essential thrombocythemia, as well as an Anti-PD-1 antibody for cancer treatment. Additionally, PharmaEssentia has licensed the development of Oraxol for certain cancers and KX01 for skin conditions like psoriasis. The company also engages in drug research initiatives, including a collaboration with Axis Therapeutics for T Cell Receptor-T therapy. Established in 2003, PharmaEssentia continues to expand its pipeline of biologics and specialty pharmaceuticals.

EirGenix Inc. is a contract development and manufacturing company based in New Taipei City, Taiwan, founded in 2012. The company operates two main business units: one focused on contract development and manufacturing services for biologics, and the other dedicated to product development, including biosimilars, biobetters, and new drugs. EirGenix offers a range of services including cell line development, process development, analytical science, quality control, and cGMP manufacturing for both mammalian and microbial systems. Additionally, the company specializes in antibody drug conjugates and provides facilities for clinical trial drug production. EirGenix is committed to ensuring that high-quality biopharmaceutical drugs are accessible and affordable for all patients.

AmMax is a clinical-stage biotechnology company focused on developing innovative therapies for diseases with significant unmet medical needs. The company leverages its CSF1R platform to create anti-inflammatory, anti-fibrotic, and anti-neovascular treatments, aiming to address a variety of critical health conditions. By pursuing licensing and partnerships, AmMax seeks to build a robust oncology portfolio that targets sizable market opportunities. Its commitment to translational and clinical development positions it to unlock the therapeutic potential of its technology, ultimately enabling healthcare professionals to offer effective treatments to patients in need.

Frequency Therapeutics is a clinical-stage biotechnology company based in Woburn, Massachusetts, that aims to repair or reverse damage from various degenerative diseases by utilizing the body’s own biological mechanisms. The company employs a Progenitor Cell Activation approach, which involves the use of small molecules to activate progenitor cells and promote the regeneration of functional tissue. Its leading product candidate, FX-322, is currently undergoing phase 2a clinical trials to address the underlying causes of sensorineural hearing loss. In addition to hearing loss, Frequency Therapeutics is also exploring treatments for a range of other conditions, including multiple sclerosis and diseases affecting muscle, the gastrointestinal tract, skin, and bone. The company has established a collaboration with Astellas Pharma for the development and commercialization of FX-322. Founded in 2014, Frequency Therapeutics focuses on disease modification without the complexities associated with genetic engineering.

C4 Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapeutic candidates that target and eliminate disease-causing proteins, primarily for the treatment of cancer and neurodegenerative disorders. The company's lead product candidate, CFT7455, is an orally bioavailable degrader designed to target IKZF1/3 for multiple myeloma and other lymphomas. Additionally, C4 is advancing CFT8634, which targets BRD9 for specific solid tumors, alongside programs aimed at genetically defined resistant solid tumors. C4 Therapeutics utilizes its proprietary Degronimid platform, which allows for the selective degradation of proteins through the natural ubiquitin/proteasome system, potentially addressing previously undruggable targets while minimizing drug resistance. The company has formed strategic collaborations with major industry players, and it aims to make a significant impact on the treatment landscape through its advanced protein degradation science and multiple development programs. Founded in 2015 and headquartered in Watertown, Massachusetts, C4 Therapeutics continues to innovate in the field of targeted therapy.

AIxMed, founded in 2018 and based in Santa Clara, California, focuses on enhancing patient care through its advanced digital cytology platform. The company leverages artificial intelligence to assist pathologists in digitizing 3D cytology samples quickly and extracting critical clinical insights in seconds. Its platform is specifically designed for bladder cancer monitoring and diagnosis, aiming to simplify the diagnostic process for healthcare professionals while reducing the complexities and costs associated with cancer care. Through these innovations, AIxMed seeks to improve patient outcomes and streamline cancer-related healthcare services.

SyneuRx International Taiwan is a biomedical company focused on developing treatments for central nervous system-related disorders, specifically schizophrenia, depression, and dementia. The company is engaged in the clinical development of several drug candidates, including SND-11, SND-12, and SND-13, with SND-13 currently in Phase IIb/III trials aimed at providing add-on therapy for schizophrenia. Through its research and development efforts, SyneuRx aims to address the significant unmet needs in mental health care, contributing to improved treatment options for patients suffering from these conditions.

TFBS Bioscience is a Contract Research Organization based in Taiwan that offers a variety of biological testing services. The company specializes in viral vector manufacturing for cell and gene therapy products, along with biosafety testing and product release testing for these therapies, vaccines, and other biologic products. Additionally, TFBS Bioscience provides cell bank characterization, viral clearance, bulk and lot release testing, assay development both in vitro and in vivo, clinical sample analysis, and cleaning validation for reusable medical devices. Through its comprehensive service offerings, TFBS Bioscience supports the advancement of biopharmaceutical development and ensures compliance with safety standards.

FaceHeart is a developer of advanced image processing technology that enables the rapid assessment of vital signs through facial video analysis. Its flagship product, FaceHeart Vitals, captures six key vital signs in just 45 seconds without the need for physical contact. This innovative solution can be seamlessly integrated into devices equipped with cameras, making it suitable for a variety of applications in telehealth, elderly care, wellness, and childcare. By leveraging artificial intelligence and deep learning, FaceHeart aims to provide real-time physiological information and enhance understanding of users' health, contributing to a safer and healthier living environment in various sectors, including medical treatment and transportation.

Bigfoot Biomedical, Inc. is a medical device company focused on transforming diabetes care for individuals with Type 1 Diabetes. Established in 2014 and based in Milpitas, California, the company specializes in developing an integrated diabetes management system that features cloud connectivity and human-centered automation. This system optimizes insulin dosing and delivery through a combination of automated infusion pumps and connected insulin pen options. Bigfoot Biomedical's innovative approach employs machine learning and user-friendly technologies to alleviate the cognitive, emotional, and financial burdens associated with insulin-requiring diabetes. By offering a comprehensive digital drug delivery platform through a unique monthly subscription service model, the company aims to enhance the quality of life for patients managing their diabetes.

Regenacy Pharmaceuticals, LLC is a biopharmaceutical company based in Boston, Massachusetts, founded in 2016. The company focuses on developing innovative treatments for peripheral neuropathies, hemoglobinopathies, and certain oncology indications. Its approach centers on the regeneration of normal protein function through the use of oral, isoform-selective histone deacetylase (HDAC) inhibitors. Notably, Regenacy is advancing the selective HDAC6 inhibitor ricolinostat, which has potential applications in treating sickle cell disease and beta-thalassemia. Through its novel, disease-modifying strategies, Regenacy aims to address significant unmet medical needs in these therapeutic areas.

Xgene Pharmaceutical Inc. is a late-clinical stage pharmaceutical company established in 2015, based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Utilizing proprietary linker technology, Xgene creates novel, multimodal conjugated molecules that enhance the efficacy and tolerability of pain medications. The company's current programs are dedicated to addressing unmet needs in neurological disorders, making significant strides in the development of innovative treatments for these conditions.

Point Robotics Medtech is an orthopedic and spine robot that optimizes clinical outcomes for patients and physicians. The company received FDA clearance for its Kinguide Robotic-Assisted Surgical System, a handheld robot that can be used in orthopedic surgeries.

Light Field Lab, Inc. is a technology startup focused on developing holographic capture display systems. Founded in 2017 and based in San Jose, California, the company creates innovative solutions that generate three-dimensional holographic images that can be viewed from multiple angles without the need for head-mounted devices. Its technology aims to project 3D holograms into living spaces, allowing users to experience immersive visuals that respond dynamically to their viewpoint. Additionally, Light Field Lab offers integrated processing and imaging solutions designed to deliver these visuals over commercial network speeds. The company is also working on a universal application programming interface to facilitate the adaptation of existing content for its holographic displays. With a mission to enable a holographic future, Light Field Lab seeks to unlock new business opportunities across both consumer and enterprise markets.

Aesop Technology is a developer of artificial intelligence solutions focused on reducing prescription-related errors and enhancing patient safety. Founded in 2019 and based in Berkeley, California, the company offers MedGuard, an AI-enhanced safety system that supports various aspects of prescription management, including prescribing, dispensing, administering, and compliance services. Aesop Technology also provides a clinical decision support system that assists healthcare providers by flagging inappropriate prescriptions based on patient diagnosis, age, and gender. By leveraging machine learning, the company's technology aims to improve healthcare quality and safety while streamlining billing-related documentation, ultimately enhancing patient safety and the accuracy of medical billing.

Avesha is a technology platform that specializes in enhancing application workloads across cloud, multi-cloud, and edge environments. Founded in 2019 and headquartered in Burlington, Massachusetts, the company offers a solution that improves business outcomes by facilitating automation and enabling high-performance, low-latency applications. Avesha's software simplifies the visibility and segmentation of applications across various clusters, which aids in security, resiliency, and overall quality of experience. Its Smart Network Application Platform (SNAP) creates a virtual overlay on any underlying network, allowing enterprises to efficiently distribute data and application logic closer to end-users. This capability supports multi-cloud deployments and real-time applications, making it a valuable tool for organizations seeking to optimize their application infrastructure.

Figur8, Inc. is a Boston-based company that specializes in developing advanced wearable sensors to monitor body movement as a biomarker for musculoskeletal (MSK) conditions. Founded in 2016 as a spin-off from MIT, Figur8 combines smart biosensors, intuitive software, and artificial intelligence to analyze MSK health data. The technology captures three-dimensional skeletal movement and muscle output, allowing for objective assessment of musculoskeletal performance and recovery. This innovative solution provides valuable insights throughout the entire care process, from injury to full recovery, ultimately reducing healthcare costs, improving access to treatment, and empowering patients to manage their own MSK health effectively.

Verana Networks, Inc., founded in 2019 and located in Waltham, Massachusetts, specializes in developing innovative 5G Radio Access Network solutions for service providers utilizing licensed millimeter wave (mmWave) spectrum. The company focuses on this spectrum due to its potential for significant expansion in speed and capacity, essential for the successful deployment of 5G technology. Verana's equipment aims to provide gigabit wireless connectivity, enabling mobile network operators to offer enhanced 5G services such as fixed wireless access. By delivering faster speeds and increased capacity, the company supports the creation of new applications that drive incremental revenue, which is crucial for sustaining the business case for 5G.

Nanolive SA is a Swiss company that specializes in the design and development of advanced devices for scanning living cells. Established in 2013 and headquartered in Ecublens, the company has created the 3D Cell Explorer, a technology that allows researchers to visualize the interior of living cells in three dimensions without the need for labeling or invasive techniques. This device is capable of examining various cellular processes, including cell division, organelle function, morphology, differentiation, and interactions between cells. Nanolive's technology is particularly valuable in drug monitoring and in vitro fertilization, providing crucial insights for researchers in the fields of drug development and therapeutic discovery. The company's innovative approach aims to enhance the understanding of cellular dynamics, ultimately contributing to advancements in medical research and treatment.

Light Field Lab, Inc. is a technology startup focused on developing holographic capture display systems. Founded in 2017 and based in San Jose, California, the company creates innovative solutions that generate three-dimensional holographic images that can be viewed from multiple angles without the need for head-mounted devices. Its technology aims to project 3D holograms into living spaces, allowing users to experience immersive visuals that respond dynamically to their viewpoint. Additionally, Light Field Lab offers integrated processing and imaging solutions designed to deliver these visuals over commercial network speeds. The company is also working on a universal application programming interface to facilitate the adaptation of existing content for its holographic displays. With a mission to enable a holographic future, Light Field Lab seeks to unlock new business opportunities across both consumer and enterprise markets.

Canner is a provider of data management solutions that enables businesses to navigate the complexities of data and its context effectively. The company has developed a universal semantic layer powered by artificial intelligence, which harmonizes various aspects of data, including schema, structure, relationships, and metadata. This innovative solution fundamentally transforms how organizations interact with their data. Canner's flagship offerings include Canner Enterprise, an enterprise-grade semantic layer, and WrenAI, an open-source AI agent and semantic framework. Additionally, Canner offers a content management system that facilitates the management, auditing, analysis, and sharing of data within a unified platform, providing clients with a consolidated view of their data across the organization.

URSROBOT Inc is a leading company specializing in service robotic solutions, dedicated to bringing outdoor service robots into various aspects of daily life. With NEXMOW, we built up the robotic lawnmower solution for commercial landscaping industry. This revolutionary device combines precise outdoor navigation, AI path planning and cloud services, setting smart working way in commercial landscaping industry. With NEXMOW "drop, mow & go" solution, it can help redeploy labors and create productivities.

Pavilion Data Systems Inc. is a technology company that specializes in designing and developing NVMe-over-Fabric storage platforms tailored for massively-parallel applications. Established in 2011 and headquartered in San Jose, California, with additional offices in the Netherlands and India, the company aims to enhance storage performance and efficiency for various sectors, including financial services, government, cloud service providers, and media and entertainment. Pavilion's innovative architecture offers a new category of storage solutions known as Hyperparallel Flash Arrays, which utilize multiple controllers to achieve ultra-low latency and linear scalability, surpassing the limitations of traditional all-flash arrays. The company's offerings include the Pavilion Data OS, which supports Internet and SaaS businesses in delivering critical applications, alongside its OPENCHOICE model that redefines storage procurement and deployment strategies. Through its advanced technology and experienced team, Pavilion Data Systems is positioned as a leader in the evolving landscape of enterprise storage solutions.

Windgap Medical Inc. is a biotechnology company that specializes in the manufacture of compact epinephrine autoinjectors designed for the treatment of anaphylaxis, a severe allergic reaction. Established in 2011, the company is headquartered in Watertown, Massachusetts. Windgap Medical's innovative auto-injectors are filled with heat-stable epinephrine, which enhances the temperature resilience and shelf life of the medication. This feature allows healthcare providers to effectively administer epinephrine to patients experiencing acute allergy attacks, improving their chances of recovery during critical moments.

Appaegis simplifies enterprise data access while enforcing strong zero-trust security for remote access. Its patent-pending solution protects data access and gives administrators full control over how enterprise data is used. The company was founded by security veterans with successful security track records.

Landing AI is a company that specializes in artificial intelligence transformation programs tailored for the manufacturing industry. Founded in 2017 and based in Palo Alto, California, the company develops solutions focused on visual inspection, automation, calibration, and automated issue identification. Its offerings cater to a diverse range of sectors, including manufacturing, retail, automotive, agriculture, telecommunications, and pharmaceuticals. The company aims to empower organizations to become AI-driven by providing a platform that enhances the accuracy of machine learning models through effective data generation and labeling. This platform helps identify environmental issues and alerts users to model changes, thereby facilitating efficient data management and accelerating troubleshooting processes. Founded by Dr. Andrew Ng, a prominent figure in AI, Landing AI is positioned to deliver practical AI solutions that drive value for businesses globally.

Pavilion Data Systems Inc. is a technology company that specializes in designing and developing NVMe-over-Fabric storage platforms tailored for massively-parallel applications. Established in 2011 and headquartered in San Jose, California, with additional offices in the Netherlands and India, the company aims to enhance storage performance and efficiency for various sectors, including financial services, government, cloud service providers, and media and entertainment. Pavilion's innovative architecture offers a new category of storage solutions known as Hyperparallel Flash Arrays, which utilize multiple controllers to achieve ultra-low latency and linear scalability, surpassing the limitations of traditional all-flash arrays. The company's offerings include the Pavilion Data OS, which supports Internet and SaaS businesses in delivering critical applications, alongside its OPENCHOICE model that redefines storage procurement and deployment strategies. Through its advanced technology and experienced team, Pavilion Data Systems is positioned as a leader in the evolving landscape of enterprise storage solutions.

Ethernovia is focused on creating a sophisticated Ethernet system capable of meeting the increasing bandwidth demands of future automotive technologies. The company's system integrates multiple levels of vehicle networks, allowing for significant advancements in vehicle design and construction. Key features of Ethernovia's solution include autonomous expansions, enhanced security intelligence, and optimized sensor bandwidths, all of which contribute to a unified network. This innovative approach enables clients to effectively transform and develop advanced vehicles, fundamentally changing how automotive systems are architected and built.

Elixiron Immunotherapeutics is focused on developing innovative therapeutics for cancer, neurological diseases, and inflammatory disorders. The company specializes in immuno-therapeutics aimed at addressing conditions such as neurodegenerative diseases and Hepatitis B, as well as various cancer types. Its drug candidates are designed to target specific immuno-suppressive pathways, including graft-versus-host disease and macrophage activation syndrome. By doing so, Elixiron seeks to empower patients to effectively utilize their immune systems in the fight against these serious health challenges.

AEye, Inc. develops advanced vision hardware, software, and algorithms for autonomous vehicles and driver-assistance systems. Based in Dublin, California, the company offers a range of products including the 4Sight Intelligent Sensing Platform, which integrates solid-state lidar with low-light cameras and artificial intelligence to provide precise and reliable perception of surroundings. AEye's unique software-defined lidar solutions are designed for dynamic applications in vehicle autonomy, smart infrastructure, and logistics, focusing on delivering faster and more accurate information. The company's notable products include the 4Sight A and 4Sight M sensors, as well as the AE100 and AE200 robotic perception systems, which cater to the mobility market. AEye operates globally, with offices in Germany, Korea, and the United States, and primarily generates revenue from customers in the United States, followed by Europe and the Asia-Pacific region.

SafeLiShare is a developer of data security software designed to assist enterprises in securely publishing and sharing sensitive data and programmatic assets. The company's technology enables organizations to safely utilize and share their valuable digital assets, facilitating the generation of business insights, machine learning, and other analytics on sensitive information. By providing a platform that allows clients to unlock new revenue streams and derive insights from their sensitive data, SafeLiShare addresses the challenges faced by enterprises in managing and leveraging their private information effectively.

KDAN specializes in AI-driven workflow and data solutions that enhance operational efficiency and organizational agility. The company offers a range of digital tools, including document management and e-signature services, to support business growth and decision-making.

Figur8, Inc. is a Boston-based company that specializes in developing advanced wearable sensors to monitor body movement as a biomarker for musculoskeletal (MSK) conditions. Founded in 2016 as a spin-off from MIT, Figur8 combines smart biosensors, intuitive software, and artificial intelligence to analyze MSK health data. The technology captures three-dimensional skeletal movement and muscle output, allowing for objective assessment of musculoskeletal performance and recovery. This innovative solution provides valuable insights throughout the entire care process, from injury to full recovery, ultimately reducing healthcare costs, improving access to treatment, and empowering patients to manage their own MSK health effectively.

Cognito Health focuses on enhancing the healthcare environment by delivering value to both patients and healthcare systems. The company has developed a global healthcare device that employs predictive algorithms to monitor patients continuously, providing a data-driven, contact-free solution. This technology alerts healthcare professionals to potential patient safety issues before they arise, such as the need for repositioning to prevent pressure-related injuries. By visually mapping pressure points, Cognito Health enables clinicians to respond proactively, improving patient outcomes and optimizing care delivery.

ARRIS specializes in additive molding technology for creating advanced performance composites tailored for mass-market applications such as aerospace, automotive, and consumer products. The company’s innovative manufacturing process focuses on the precise alignment of continuous carbon fibers, allowing for the integration of electronic components and multifunctional materials into a single, topologically optimized part. This technology enables clients to leverage high-performance composites, enhancing the capabilities and efficiency of their products while meeting the demands of modern manufacturing.

Oculii develops advanced AI software for radar systems, aiming to enhance resolution, range, and accuracy while reducing costs compared to traditional solutions. Its technology is essential for the advancement of autonomous vehicles, which require reliable and high-performance perception capabilities in all weather conditions. By utilizing Virtual Aperture Imaging, Oculii's software allows existing radar hardware to achieve higher angular resolution without the need for increased physical antenna count. This innovation enables the extraction of detailed 4D positioning information from low-cost, off-the-shelf radar components, paving the way for improved radar imaging. Oculii collaborates with leading companies in autonomous vehicles, robotics, and drones, positioning itself as a key player in the development of affordable and effective perception technologies for the future of autonomy.

Touché Solutions, previously known as Mechavision, specializes in the development of robotic technology platforms, particularly focusing on IoT sensor modules and smart manufacturing applications. The company manufactures robot sensor modules and offers advanced plug-in robot haptic technology products, which have been integrated into Qisda's human-machine collaboration production line. Through its commitment to research and development, Touché Solutions aims to enhance the efficiency of intelligent robotic development for its clients, thereby advancing the capabilities of robotics in various industrial applications.

Ubiik Technology, founded in 2016, specializes in Advanced Metering Infrastructure (AMI) and private LTE (pLTE) solutions. The company leverages its proprietary Weightless™ and cellular IoT LPWAN technologies to offer low-power wireless devices that connect multiple devices to a single base station. Ubiik initially focused on providing Weightless™ LPWAN, a high-performance open standard communication protocol, which has been successfully implemented in various AMI projects. Following a successful deployment in 2018, the company expanded its offerings to include a Platform as a Service (PaaS) model, positioning itself as a vertical IoT solutions provider. Ubiik's connectivity solutions now encompass LTE technologies, catering to the diverse needs of the IoT market, particularly for applications requiring robust security compliant with 3GPP standards.

Suono Bio, Inc. is a biotechnology company based in Medford, Massachusetts, focused on developing innovative therapeutic products utilizing its proprietary delivery technology. Founded in 2016, the company specializes in the ultra-rapid, localized delivery of small molecules, biologics, nucleic acids, and gene therapies directly to the gastrointestinal tract, eliminating the need for encapsulation. Suono Bio aims to transform the treatment of challenging diseases, particularly those involving inflammatory-mediated conditions, by enabling efficient and effective delivery of therapeutics across various tissues. This technology has the potential to enhance patient recovery from gastrointestinal diseases by ensuring that treatments reach their intended targets quickly and effectively.

Avesha is a technology platform that specializes in enhancing application workloads across cloud, multi-cloud, and edge environments. Founded in 2019 and headquartered in Burlington, Massachusetts, the company offers a solution that improves business outcomes by facilitating automation and enabling high-performance, low-latency applications. Avesha's software simplifies the visibility and segmentation of applications across various clusters, which aids in security, resiliency, and overall quality of experience. Its Smart Network Application Platform (SNAP) creates a virtual overlay on any underlying network, allowing enterprises to efficiently distribute data and application logic closer to end-users. This capability supports multi-cloud deployments and real-time applications, making it a valuable tool for organizations seeking to optimize their application infrastructure.

AEye, Inc. develops advanced vision hardware, software, and algorithms for autonomous vehicles and driver-assistance systems. Based in Dublin, California, the company offers a range of products including the 4Sight Intelligent Sensing Platform, which integrates solid-state lidar with low-light cameras and artificial intelligence to provide precise and reliable perception of surroundings. AEye's unique software-defined lidar solutions are designed for dynamic applications in vehicle autonomy, smart infrastructure, and logistics, focusing on delivering faster and more accurate information. The company's notable products include the 4Sight A and 4Sight M sensors, as well as the AE100 and AE200 robotic perception systems, which cater to the mobility market. AEye operates globally, with offices in Germany, Korea, and the United States, and primarily generates revenue from customers in the United States, followed by Europe and the Asia-Pacific region.

Tripresso is an online travel agent based in Taipei, Taiwan, established in 2013. Initially, it focused on creating an online marketplace for package tour suppliers, such as Lions Travel and Richmond, while also developing a user-friendly search engine for customers to find suitable travel products. Over time, Tripresso expanded its offerings to include hotels, flight tickets, and customized travel plans for outbound travel. In 2018, the company introduced TripSaaS, a proprietary software-as-a-service system designed to assist traditional travel agencies in managing their websites, product listings, orders, and customer relationships, thereby improving operational efficiency. By leveraging data and partnerships from both online and offline sources, Tripresso aims to streamline travel planning and provide users with affordable travel packages.

Mammoth Cyber specializes in computer and network security, offering an agentless zero-trust access system aimed at securing remote, data, and web access. The company's innovative technology effectively blocks attacks from zero-day exploits, ensuring that enterprise data remains protected within its secure access service edge framework. This solution is adaptable to various architectures, platforms, and existing product portfolios, allowing clients to maintain comprehensive visibility and control over user interactions with applications.

Dcard is a social networking platform founded in 2015 and based in Taipei, Taiwan. It serves as the largest anonymous communication platform in the country, specifically designed to connect students within the campus community. Dcard allows users to share ideas and experiences freely, fostering a comfortable and trustworthy environment for interaction. The platform emphasizes inclusivity, enabling individuals from diverse backgrounds, ages, and interests to participate in discussions and exchanges without the constraints of identity.

Viracta Therapeutics, Inc. is a clinical-stage drug development company based in Cardiff, California, that specializes in precision oncology focused on virus-associated malignancies. The company utilizes a viral activation therapy platform to develop treatments for cancers linked to the Epstein-Barr Virus (EBV) and other virus-related diseases. Its lead investigational drug, nanatinostat, is being evaluated in combination with the antiviral valganciclovir as a potential oral therapy for EBV-positive lymphoma, including post-transplant lymphoproliferative disorder, plasmablastic lymphoma, and angioimmunoblastic T cell lymphoma. Viracta is also exploring the application of this approach to other EBV-associated conditions, such as nasopharyngeal carcinoma and gastric carcinoma. Founded in 2007 and rebranded from HemaQuest Pharmaceuticals in 2015, Viracta Therapeutics is actively conducting multiple clinical trials to advance its therapeutic candidates.

Ambiq Micro, Inc. specializes in the development of ultra-low power integrated circuits tailored for power-sensitive applications. The company focuses on creating subthreshold power optimized technology, producing real-time clocks and microcontrollers for various uses, including wearables, smart cards, wireless sensors, and Internet-of-Things (IoT) devices. Founded in 2009 and based in Austin, Texas, Ambiq Micro also maintains offices in San Jose, California, and several locations in China. Its pioneering technology aims to facilitate the creation of next-generation wireless electronics by enabling innovative companies to design products that minimize battery dependency, reduce overall power consumption, and enhance design flexibility. Additionally, Ambiq Micro provides technical support services to its clients, further contributing to its mission of advancing low-power semiconductor solutions.

Artilux specializes in the development of innovative technology solutions focused on optical connectivity and 3D time of flight (ToF) applications. The company offers a range of integrated circuit (IC) solutions that deliver high performance at competitive costs, catering to both short-range applications, such as consumer electronics with 10-40G capabilities, and long-range data center links with 100G performance. Artilux is also recognized for its discovery of GeSi, a groundbreaking 3D photosensitive material, which is poised to enhance the functionality of next-generation mobile devices. By incorporating advanced optical and radio frequency technologies, Artilux enables seamless data transfer for various applications, from everyday consumer use to complex cloud-based systems.

C4 Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapeutic candidates that target and eliminate disease-causing proteins, primarily for the treatment of cancer and neurodegenerative disorders. The company's lead product candidate, CFT7455, is an orally bioavailable degrader designed to target IKZF1/3 for multiple myeloma and other lymphomas. Additionally, C4 is advancing CFT8634, which targets BRD9 for specific solid tumors, alongside programs aimed at genetically defined resistant solid tumors. C4 Therapeutics utilizes its proprietary Degronimid platform, which allows for the selective degradation of proteins through the natural ubiquitin/proteasome system, potentially addressing previously undruggable targets while minimizing drug resistance. The company has formed strategic collaborations with major industry players, and it aims to make a significant impact on the treatment landscape through its advanced protein degradation science and multiple development programs. Founded in 2015 and headquartered in Watertown, Massachusetts, C4 Therapeutics continues to innovate in the field of targeted therapy.

Pavilion Data Systems Inc. is a technology company that specializes in designing and developing NVMe-over-Fabric storage platforms tailored for massively-parallel applications. Established in 2011 and headquartered in San Jose, California, with additional offices in the Netherlands and India, the company aims to enhance storage performance and efficiency for various sectors, including financial services, government, cloud service providers, and media and entertainment. Pavilion's innovative architecture offers a new category of storage solutions known as Hyperparallel Flash Arrays, which utilize multiple controllers to achieve ultra-low latency and linear scalability, surpassing the limitations of traditional all-flash arrays. The company's offerings include the Pavilion Data OS, which supports Internet and SaaS businesses in delivering critical applications, alongside its OPENCHOICE model that redefines storage procurement and deployment strategies. Through its advanced technology and experienced team, Pavilion Data Systems is positioned as a leader in the evolving landscape of enterprise storage solutions.

EirGenix Inc. is a contract development and manufacturing company based in New Taipei City, Taiwan, founded in 2012. The company operates two main business units: one focused on contract development and manufacturing services for biologics, and the other dedicated to product development, including biosimilars, biobetters, and new drugs. EirGenix offers a range of services including cell line development, process development, analytical science, quality control, and cGMP manufacturing for both mammalian and microbial systems. Additionally, the company specializes in antibody drug conjugates and provides facilities for clinical trial drug production. EirGenix is committed to ensuring that high-quality biopharmaceutical drugs are accessible and affordable for all patients.

ARRIS specializes in additive molding technology for creating advanced performance composites tailored for mass-market applications such as aerospace, automotive, and consumer products. The company’s innovative manufacturing process focuses on the precise alignment of continuous carbon fibers, allowing for the integration of electronic components and multifunctional materials into a single, topologically optimized part. This technology enables clients to leverage high-performance composites, enhancing the capabilities and efficiency of their products while meeting the demands of modern manufacturing.

Regenacy Pharmaceuticals, LLC is a biopharmaceutical company based in Boston, Massachusetts, founded in 2016. The company focuses on developing innovative treatments for peripheral neuropathies, hemoglobinopathies, and certain oncology indications. Its approach centers on the regeneration of normal protein function through the use of oral, isoform-selective histone deacetylase (HDAC) inhibitors. Notably, Regenacy is advancing the selective HDAC6 inhibitor ricolinostat, which has potential applications in treating sickle cell disease and beta-thalassemia. Through its novel, disease-modifying strategies, Regenacy aims to address significant unmet medical needs in these therapeutic areas.

Landing AI is a company that specializes in artificial intelligence transformation programs tailored for the manufacturing industry. Founded in 2017 and based in Palo Alto, California, the company develops solutions focused on visual inspection, automation, calibration, and automated issue identification. Its offerings cater to a diverse range of sectors, including manufacturing, retail, automotive, agriculture, telecommunications, and pharmaceuticals. The company aims to empower organizations to become AI-driven by providing a platform that enhances the accuracy of machine learning models through effective data generation and labeling. This platform helps identify environmental issues and alerts users to model changes, thereby facilitating efficient data management and accelerating troubleshooting processes. Founded by Dr. Andrew Ng, a prominent figure in AI, Landing AI is positioned to deliver practical AI solutions that drive value for businesses globally.

AEye, Inc. develops advanced vision hardware, software, and algorithms for autonomous vehicles and driver-assistance systems. Based in Dublin, California, the company offers a range of products including the 4Sight Intelligent Sensing Platform, which integrates solid-state lidar with low-light cameras and artificial intelligence to provide precise and reliable perception of surroundings. AEye's unique software-defined lidar solutions are designed for dynamic applications in vehicle autonomy, smart infrastructure, and logistics, focusing on delivering faster and more accurate information. The company's notable products include the 4Sight A and 4Sight M sensors, as well as the AE100 and AE200 robotic perception systems, which cater to the mobility market. AEye operates globally, with offices in Germany, Korea, and the United States, and primarily generates revenue from customers in the United States, followed by Europe and the Asia-Pacific region.

Ambiq Micro, Inc. specializes in the development of ultra-low power integrated circuits tailored for power-sensitive applications. The company focuses on creating subthreshold power optimized technology, producing real-time clocks and microcontrollers for various uses, including wearables, smart cards, wireless sensors, and Internet-of-Things (IoT) devices. Founded in 2009 and based in Austin, Texas, Ambiq Micro also maintains offices in San Jose, California, and several locations in China. Its pioneering technology aims to facilitate the creation of next-generation wireless electronics by enabling innovative companies to design products that minimize battery dependency, reduce overall power consumption, and enhance design flexibility. Additionally, Ambiq Micro provides technical support services to its clients, further contributing to its mission of advancing low-power semiconductor solutions.

Metanoia Communications Inc., established in 2004 and based in Hsinchu City, Taiwan, specializes in the development of semiconductor and software solutions for the wireline broadband and in-home networking markets. The company manufactures high-speed PHY chipsets, including products for VDSL2, G.fast, and G.hn technologies. With a focus on state-of-the-art system architecture and algorithm expertise, Metanoia delivers a diverse range of fixed-line communication products designed to meet the needs of broadband manufacturers. As a subsidiary of ELAN Microelectronics Corporation, Metanoia combines extensive integrated circuit design capabilities with innovative technology to support the growing demand for high-speed broadband connectivity.

DSP Concepts Inc. specializes in the development of audio tools and intellectual property for audio-enabled products. The company is known for its flagship platform, Audio Weaver, which is a cross-platform audio processing engine that facilitates the creation and delivery of audio features for a variety of applications. DSP Concepts also offers TalkTo, a suite of machine learning algorithms designed to enhance microphone performance in challenging acoustic environments. Additionally, the company provides a software-based asynchronous sample rate converter and a range of design and consulting services, including automotive audio design, system architecture consultation, and custom protocol development. Its technologies are utilized in numerous automotive and consumer products, serving a diverse clientele that includes well-known brands in the automotive and smart home sectors. Founded in 2003 and headquartered in Santa Clara, California, DSP Concepts operates additional offices in Dedham, Massachusetts; Germany; and China.

Oculii develops advanced AI software for radar systems, aiming to enhance resolution, range, and accuracy while reducing costs compared to traditional solutions. Its technology is essential for the advancement of autonomous vehicles, which require reliable and high-performance perception capabilities in all weather conditions. By utilizing Virtual Aperture Imaging, Oculii's software allows existing radar hardware to achieve higher angular resolution without the need for increased physical antenna count. This innovation enables the extraction of detailed 4D positioning information from low-cost, off-the-shelf radar components, paving the way for improved radar imaging. Oculii collaborates with leading companies in autonomous vehicles, robotics, and drones, positioning itself as a key player in the development of affordable and effective perception technologies for the future of autonomy.

Oculii develops advanced AI software for radar systems, aiming to enhance resolution, range, and accuracy while reducing costs compared to traditional solutions. Its technology is essential for the advancement of autonomous vehicles, which require reliable and high-performance perception capabilities in all weather conditions. By utilizing Virtual Aperture Imaging, Oculii's software allows existing radar hardware to achieve higher angular resolution without the need for increased physical antenna count. This innovation enables the extraction of detailed 4D positioning information from low-cost, off-the-shelf radar components, paving the way for improved radar imaging. Oculii collaborates with leading companies in autonomous vehicles, robotics, and drones, positioning itself as a key player in the development of affordable and effective perception technologies for the future of autonomy.

Tripresso is an online travel agent based in Taipei, Taiwan, established in 2013. Initially, it focused on creating an online marketplace for package tour suppliers, such as Lions Travel and Richmond, while also developing a user-friendly search engine for customers to find suitable travel products. Over time, Tripresso expanded its offerings to include hotels, flight tickets, and customized travel plans for outbound travel. In 2018, the company introduced TripSaaS, a proprietary software-as-a-service system designed to assist traditional travel agencies in managing their websites, product listings, orders, and customer relationships, thereby improving operational efficiency. By leveraging data and partnerships from both online and offline sources, Tripresso aims to streamline travel planning and provide users with affordable travel packages.

Viracta Therapeutics, Inc. is a clinical-stage drug development company based in Cardiff, California, that specializes in precision oncology focused on virus-associated malignancies. The company utilizes a viral activation therapy platform to develop treatments for cancers linked to the Epstein-Barr Virus (EBV) and other virus-related diseases. Its lead investigational drug, nanatinostat, is being evaluated in combination with the antiviral valganciclovir as a potential oral therapy for EBV-positive lymphoma, including post-transplant lymphoproliferative disorder, plasmablastic lymphoma, and angioimmunoblastic T cell lymphoma. Viracta is also exploring the application of this approach to other EBV-associated conditions, such as nasopharyngeal carcinoma and gastric carcinoma. Founded in 2007 and rebranded from HemaQuest Pharmaceuticals in 2015, Viracta Therapeutics is actively conducting multiple clinical trials to advance its therapeutic candidates.

Pavilion Data Systems Inc. is a technology company that specializes in designing and developing NVMe-over-Fabric storage platforms tailored for massively-parallel applications. Established in 2011 and headquartered in San Jose, California, with additional offices in the Netherlands and India, the company aims to enhance storage performance and efficiency for various sectors, including financial services, government, cloud service providers, and media and entertainment. Pavilion's innovative architecture offers a new category of storage solutions known as Hyperparallel Flash Arrays, which utilize multiple controllers to achieve ultra-low latency and linear scalability, surpassing the limitations of traditional all-flash arrays. The company's offerings include the Pavilion Data OS, which supports Internet and SaaS businesses in delivering critical applications, alongside its OPENCHOICE model that redefines storage procurement and deployment strategies. Through its advanced technology and experienced team, Pavilion Data Systems is positioned as a leader in the evolving landscape of enterprise storage solutions.

Light Field Lab, Inc. is a technology startup focused on developing holographic capture display systems. Founded in 2017 and based in San Jose, California, the company creates innovative solutions that generate three-dimensional holographic images that can be viewed from multiple angles without the need for head-mounted devices. Its technology aims to project 3D holograms into living spaces, allowing users to experience immersive visuals that respond dynamically to their viewpoint. Additionally, Light Field Lab offers integrated processing and imaging solutions designed to deliver these visuals over commercial network speeds. The company is also working on a universal application programming interface to facilitate the adaptation of existing content for its holographic displays. With a mission to enable a holographic future, Light Field Lab seeks to unlock new business opportunities across both consumer and enterprise markets.

Frequency Therapeutics is a clinical-stage biotechnology company based in Woburn, Massachusetts, that aims to repair or reverse damage from various degenerative diseases by utilizing the body’s own biological mechanisms. The company employs a Progenitor Cell Activation approach, which involves the use of small molecules to activate progenitor cells and promote the regeneration of functional tissue. Its leading product candidate, FX-322, is currently undergoing phase 2a clinical trials to address the underlying causes of sensorineural hearing loss. In addition to hearing loss, Frequency Therapeutics is also exploring treatments for a range of other conditions, including multiple sclerosis and diseases affecting muscle, the gastrointestinal tract, skin, and bone. The company has established a collaboration with Astellas Pharma for the development and commercialization of FX-322. Founded in 2014, Frequency Therapeutics focuses on disease modification without the complexities associated with genetic engineering.

Touché Solutions, previously known as Mechavision, specializes in the development of robotic technology platforms, particularly focusing on IoT sensor modules and smart manufacturing applications. The company manufactures robot sensor modules and offers advanced plug-in robot haptic technology products, which have been integrated into Qisda's human-machine collaboration production line. Through its commitment to research and development, Touché Solutions aims to enhance the efficiency of intelligent robotic development for its clients, thereby advancing the capabilities of robotics in various industrial applications.

Tricorntech specializes in semiconductor process control, environmental monitoring, and pollution detection. The company offers a range of services, including the detection of volatile organic compounds and rapid air quality analysis applicable in various settings, from cleanrooms to urban environments. Its product offerings focus on ensuring quality assurance in semiconductor processes, as well as monitoring groundwater and soil contamination. Tricorntech serves a diverse clientele across multiple sectors, including semiconductor manufacturing, steel production, petrochemicals, food processing, healthcare, and public environmental services.

Ambiq Micro, Inc. specializes in the development of ultra-low power integrated circuits tailored for power-sensitive applications. The company focuses on creating subthreshold power optimized technology, producing real-time clocks and microcontrollers for various uses, including wearables, smart cards, wireless sensors, and Internet-of-Things (IoT) devices. Founded in 2009 and based in Austin, Texas, Ambiq Micro also maintains offices in San Jose, California, and several locations in China. Its pioneering technology aims to facilitate the creation of next-generation wireless electronics by enabling innovative companies to design products that minimize battery dependency, reduce overall power consumption, and enhance design flexibility. Additionally, Ambiq Micro provides technical support services to its clients, further contributing to its mission of advancing low-power semiconductor solutions.

Frequency Therapeutics is a clinical-stage biotechnology company based in Woburn, Massachusetts, that aims to repair or reverse damage from various degenerative diseases by utilizing the body’s own biological mechanisms. The company employs a Progenitor Cell Activation approach, which involves the use of small molecules to activate progenitor cells and promote the regeneration of functional tissue. Its leading product candidate, FX-322, is currently undergoing phase 2a clinical trials to address the underlying causes of sensorineural hearing loss. In addition to hearing loss, Frequency Therapeutics is also exploring treatments for a range of other conditions, including multiple sclerosis and diseases affecting muscle, the gastrointestinal tract, skin, and bone. The company has established a collaboration with Astellas Pharma for the development and commercialization of FX-322. Founded in 2014, Frequency Therapeutics focuses on disease modification without the complexities associated with genetic engineering.